Biotricity and Dynatronics Stocks Compared

Analyzing the financial performance and market dynamics of two medical device companies

Published on Mar. 4, 2026

Got story updates? Submit your updates here. ›

This article compares the financial metrics, market performance, and ownership structures of Biotricity (NASDAQ:BTCY) and Dynatronics (NASDAQ:DYNT), two medical device companies operating in the physical therapy, rehabilitation, and pain management markets. The analysis covers key indicators like net margins, return on equity, revenue, earnings per share, and stock volatility to assess the relative strengths and weaknesses of the two companies.

Why it matters

Understanding the comparative performance of Biotricity and Dynatronics is valuable for investors, analysts, and industry observers to gauge the competitive landscape and growth potential in the medical device sector, particularly for products and services related to physical therapy, rehabilitation, and pain management.

The details

The analysis finds that Dynatronics outperforms Biotricity on 6 out of 11 key metrics, including higher net margins, stronger institutional ownership, and lower stock price volatility. However, Biotricity has a higher proportion of insider ownership, which can signal confidence from company leadership. Both companies operate in the same general market segments but have distinct product portfolios and geographic footprints.

  • The data and analysis in this article are current as of March 4, 2026.

The players

Biotricity

A medical technology company that provides biometric data monitoring solutions, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses.

Dynatronics

A medical device company that designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products.

Got photos? Submit your photos here. ›

The takeaway

This comparative analysis highlights the nuanced differences between Biotricity and Dynatronics, two players in the growing medical device market for physical therapy, rehabilitation, and pain management solutions. Investors and industry observers will need to weigh the relative strengths and weaknesses of each company to assess their long-term growth potential and competitive positioning.